The Walden Group is pleased to announce that it represented Attentus Medical Sales, Inc.,a provider of specialized products to compounding, specialty, and infusion pharmacies, to Medical Specialty Distributors, LLC, a leading alternate site patient supply chain solutions provider and a portfolio company of New Mountain Capital.

To serve the changing needs of compounding, specialty and other non-retail pharmacies, Attentus provides formularies of novel products, coupled with consulting and compliance advice. Its accounts include some of the largest companies in each channel, most with multiple locations throughout the U.S. Given Attentus' unique and personalized approach to the market, The Walden Group carefully collaborated with the principals to pull together the needed elements to properly convey the value and growth potential of the company. Walden helped with all aspects of the transaction and worked closely with the parties, their lawyers and other advisors to reach a successful conclusion.

About The Walden Group

The Walden Group is a healthcare investment banking and consulting firm combining merger & acquisition and strategic consulting services. Its approach is close-to-operations in lockstep with business development and C-Suite executives of medical device, diagnostic, healthcare IT, service and other companies within the sector. It represents companies seeking to divest operations and find a "home" within a larger company or private equity firm that can better commercialize its product lines.  It also represents larger operating companies and financial sponsors seeking to grow by corporate acquisition. It is expert in identifying and building rapport with strategically fitted candidates and guiding transactions to completion.